Joseph Murray, MD of the Mayo Clinic explains the potential pharmaceutical treatments for celiac disease.
In advance of the free June webinar, “Celiac Disease: Immunology 101 and the Drug Development Process,” the National Foundation for Celiac Awareness (NFCA) asked Joseph Murray, MD, Consultant, Division of Gastroenterology & Hepatology, Professor of Medicine,Mayo Clinic College of Medicine and NFCA Scientific/Medical Advisory Council Member to explain the potential pharmaceutical treatments currently in development for celiac disease.
Register for “Celiac Disease: Immunlogy 101 and the Drug Development Process,” happening on Tuesday, June 11 at 8:30 p.m. EDT/5:30 p.m. PDT here.
Opt-in to stay up-to-date on the latest news.
Yes, I want to advance research No, I'd prefer not to